NVG:NYE-Nuveen AMT Free Municipal Credit Income (USD)

FUND | Medical Distribution |

Last Closing

USD 11.85

Change

+0.02 (+0.17)%

Market Cap

N/A

Volume

0.26M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

-0.61 (-0.21%)

USD 56.66B
CAH Cardinal Health Inc

+0.05 (+0.03%)

USD 36.46B
MCK McKesson Corporation

+2.14 (+0.30%)

N/A
OMI Owens & Minor Inc

+0.95 (+14.26%)

N/A

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.81 % 0.00 %

+0.02 (+0.12%)

USD 0.01B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT VanEck CEF Municipal Inco.. 0.00 % 0.40 %

+0.02 (+0.12%)

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.34% 40% F 35% F
Dividend Return 1.93% 100% F 67% D+
Total Return -1.41% 40% F 40% F
Trailing 12 Months  
Capital Gain -2.39% 40% F 37% F
Dividend Return 5.86% 100% F 80% B-
Total Return 3.47% 40% F 47% F
Trailing 5 Years  
Capital Gain -22.85% 20% F 19% F
Dividend Return 23.91% 100% F 66% D+
Total Return 1.06% 40% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain -4.93% 20% F 15% F
Dividend Return -2.05% 20% F 16% F
Total Return 2.88% 80% B- 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 21.17% 60% D- 45% F
Risk Adjusted Return -9.68% 20% F 19% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.